Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour

Improved resolution and sensitivity of [¹⁸F]MFBG PET compared with [¹²³I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour

Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):313-315. doi: 10.1007/s00259-020-04830-x. Epub 2020 May 8.

Elin Pauwels^{1

2}, Sofie Celen³, Mathilde Vandamme³, William Leysen³, Kristof Baete^{1

2}, Oliver Bechter⁴, Marie Bex⁵, Kim Serdons^{1

2}, Koen Van Laere^{1

2}, Guy Bormans³, Christophe M Deroose^{6

7}

¹ Nuclear Medicine, University Hospitals Leuven, UZ Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.
² Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
³ Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium.
⁴ Oncology, University Hospitals Leuven, Leuven, Belgium.
⁵ Endocrinology, University Hospitals Leuven, Leuven, Belgium.
⁶ Nuclear Medicine, University Hospitals Leuven, UZ Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium. christophe.deroose@uzleuven.be.
⁷ Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. christophe.deroose@uzleuven.be.

No abstract available